ritanserin has been researched along with Brain Neoplasms in 1 studies
Ritanserin: A selective and potent serotonin-2 antagonist that is effective in the treatment of a variety of syndromes related to anxiety and depression. The drug also improves the subjective quality of sleep and decreases portal pressure.
ritanserin : A thiazolopyrimidine that is 5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one which is substituted at position 7 by a methyl group and at position 6 by a 2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl group. A potent and long-acting seratonin (5-hydroxytryptamine, 5-HT) antagonist of the subtype 5-HT2 (Ki = 0.39 nM), it is used in the treatment of a variety of disorders including anxiety, depression and schizophrenia. It has little sedative action.
Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Olmez, I | 1 |
| Love, S | 1 |
| Xiao, A | 1 |
| Manigat, L | 1 |
| Randolph, P | 1 |
| McKenna, BD | 1 |
| Neal, BP | 1 |
| Boroda, S | 1 |
| Li, M | 1 |
| Brenneman, B | 1 |
| Abounader, R | 1 |
| Floyd, D | 1 |
| Lee, J | 1 |
| Nakano, I | 1 |
| Godlewski, J | 1 |
| Bronisz, A | 1 |
| Sulman, EP | 1 |
| Mayo, M | 1 |
| Gioeli, D | 1 |
| Weber, M | 1 |
| Harris, TE | 1 |
| Purow, B | 1 |
1 other study available for ritanserin and Brain Neoplasms
| Article | Year |
|---|---|
Targeting the mesenchymal subtype in glioblastoma and other cancers via inhibition of diacylglycerol kinase alpha.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Diacylglycerol Kinase; Female; Glioblastoma; Humans; Mic | 2018 |